Abiopharma

🔍 Cotton Richard John (Director)

Company: Spectral AI, Inc. (MDAI)

Report Date: 2026-04-24

Detailed Transactions and Holdings:

• Acquired 29,850 shares of Common Stock (Direct)
  Date: 2026-04-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 96,777.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 25,000 shares of Restricted Stock Unit at $1.84 per share (Derivative)
  Date: 2026-04-24 | Code: H | Expires: 2036-04-20 | shares_owned_after: 25,000.00 | Footnotes: F2
• Holds 31,460 shares of ISO at $1.67 per share (Derivative)
  Date: 2026-04-24 | Code: H | Expires: 2034-05-15 | shares_owned_after: 31,460.00 | Footnotes: F3
• Holds 27,136 shares of ISO at $1.67 per share (Derivative)
  Date: 2026-04-24 | Code: H | Expires: 2034-05-15 | shares_owned_after: 27,136.00 | Footnotes: F4
• Holds 75,000 shares of NQSO at $1.25 per share (Derivative)
  Date: 2026-04-24 | Code: H | Expires: 2035-04-23 | shares_owned_after: 75,000.00 | Footnotes: F5

Footnotes:

• F1: The total includes 29,850 restricted stock units ("RSUs"), which are fully vested and were issued on 4/24/2026.
• F2: 50% of the RSUs vested on April 20, 2026. 50% of the RSUs will vest on April 1, 2027.
• F3: 100% of the stock options vested on the date of issuance.
• F4: 100% of the stock options were vested as of the date hereof.
• F5: 25,000 of the stock options were vested as of the date hereof. The remaining 50,000 stock options vest upon the achievement of certain milestones.